Status:
COMPLETED
Confirmatory Study: Assessing the Efficacy and Safety of the AcusMu Microneedle Patch in Treating Periorbital Wrinkles
Lead Sponsor:
AcusMu Medtech Co., Ltd.
Collaborating Sponsors:
Taipei Medical University Hospital
Conditions:
Wrinkle
Eligibility:
All Genders
18-99 years
Brief Summary
The core objective of this study is to validate the safe and efficacious application of the AcusMu microneedle patch (FMD WK) to enhance the appearance of periorbital wrinkle
Detailed Description
This clinical study is a randomized, double-blind, split-face clinical trial investigating the efficacy of AcusMu (FMD WK) for the treatment of periorbital wrinkles. Participants will attend a study c...
Eligibility Criteria
Inclusion
- Participants aged 18 to 99 (regardless of race or gender).
- Diagnosed with mild or moderate periorbital wrinkles by a dermatologist.
Exclusion
- Participants with open wounds or active infections on their skin.
- Individuals involved in other studies that could interfere with this trial.
- Pregnant, breastfeeding, or planning to become pregnant during the trial.
- Those with significant medical conditions such as cancer, liver disease, diabetes, kidney disease, or cardiovascular disorders.
- Individuals who have undergone alternative treatments for periorbital wrinkles in the past six months (e.g., laser therapy, radiofrequency).
- Participants concurrently receiving alternative treatments for periorbital wrinkles.
Key Trial Info
Start Date :
November 24 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2024
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT06158867
Start Date
November 24 2023
End Date
January 31 2024
Last Update
December 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Medical University Hospital
Taipei, Taiwan